Early Phase 1 Retinitis Pigmentosa Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients

Retinitis Pigmentosa

Zhongmou Therapeutics12 enrolled1 locationNCT06292650

Recruiting

Early Phase 1

Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa

Retinitis Pigmentosa

Peking University Third Hospital9 enrolled1 locationNCT05805007

Recruiting

Early Phase 1

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

X-Linked Retinitis Pigmentosa

Frontera Therapeutics18 enrolled2 locationsNCT05874310